Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9c55cbd632f124625c19c848aaffd9c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-534 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-534 |
filingDate |
2005-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_500489e04f7bf48cfb178bf16047684b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ef200aac149fe723c8c6f6ac217a97a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6910ebb5312c99786a01a5a6031b3e2b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_861a3c1a7c25013bbeeb5000f02b4aed |
publicationDate |
2005-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2005169838-A1 |
titleOfInvention |
Radiolabeling method |
abstract |
Antibody binding assays and radiolabeling kits are disclosed for radiolabeling and testing therapeutic antibodies in the commercial setting. In particular, the kits are designed for making and evaluating radiolabeled anti-CD20 conjugates to be used for the treatment and imaging of B cell lymphoma tumors. All kit reagents are sterile and are designed to achieve a high level of antibody radiolabeling and product stability with results which are highly reproducible. |
priorityDate |
1999-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |